Caveolin and MAP kinase interaction in angiotensin II preconditioning of the myocardium

Journal of Cellular and Molecular Medicine

Volumn 11, Issue 4, 2007, Pages 788-797

  Das, Manika ^a   Das, Samarjit ^a   Das, Dipak K ^a,b  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Angiotensin II; Caveolin; Heart; Ischaemia reperfusion; MAP kinases; ROS

Indexed keywords

ACETOPHENONE DERIVATIVE; ACETYLCYSTEINE; ANGIOTENSIN II; APOCYNIN; CAVEOLIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOPROTEIN; PROTEIN BCL 2; PROTEIN KINASE B;

ANIMAL; APOPTOSIS; ARTICLE; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; HEART INFARCTION PREVENTION; HEART MUSCLE CELL; IN VITRO STUDY; METABOLISM; PROTEIN BINDING; RAT;

ACETOPHENONES; ACETYLCYSTEINE; ANGIOTENSIN II; ANIMALS; APOPTOSIS; CAVEOLINS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCYTES, CARDIAC; PHOSPHOPROTEINS; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS;

MAMMALIA; RATTUS;

EID: 34548166975     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2007.00067.x     Document Type: Article

References (38)

1. Ferreira AJ, Santos RA, Almeida AP. Angiotensin: cardio protective effect in myocardial ischemia/reperfusion. Hypertension. 2001 38 : 665 8.
2. Sharma A, Singh M. Possible mechanism of cardio protective effect of angiotensin preconditioning in isolated rat heart. Eur J Pharmacol. 2000 406 : 85 92.
3. Sharma A, Singh M. Effect of ethylisopropyl amiloride, a Na + -H + exchange inhibitor, on cardio protective effect of ischemic and angiotensin preconditioning. Mol Cell Biochem. 2000 214 : 31 8.
4. Nakano A, Miura T, Ura N, Suzuki K, Shimamoto K. Role of angiotensin II type I receptor in preconditioning against infarction. Coronary Artery Dis. 1997 8 : 343 50.
5. Diaz RJ, Wilson GJ. Selective blockade of AT1 angiotensin II receptors abolishes ischemic preconditioning in isolated rabbit hearts. J Mol Cell Cardiol. 1997 29 : 129 39.
6. Das DK, Maulik N, Engleman RM. Redox regulation of Angiotensin II signaling in the heart. J. Cell. Mol. Med. 2004 8 : 144 52.
7. Sharma A, Singh M. Effect of ethylisopropoyl amiloride, a Na + H + exchange inhibitor, on cardio protective effect of ischemic and angiotensin preconditioning. Mol. Cell. Biochem. 2000 214 : 31 8.
8. Das S, Engelman RM, Das DK. Angiotensin preconditioning of the heart: Evidence for redox signaling. Cell Biochem Biophys. 2006 44 : 103 10.
9. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 1994 74 : 1141 8.
10. Pagano PJ, Ito Y, Tornheim K, Gallop PM, Tauber AI, Cohen RA. NADPH oxidase superoxide-generating system in the rabbit aorta. Am J Physiol. 1995 268 H2274 80.
11. Maulik N, Yoshida T, Zu YL, Sato M, Banerjee A, Das DK. Ischemic preconditioning triggers tyrosine kinase signaling: a potential role for MAPKAP kinase 2. Am J Physiol. 1998 275 : H1857 64.
12. Wrobleski ST and Doweyko AM. Structural comparison of p38 inhibitor-protein complexes: a review of recent p38 inhibitors having unique binding interactions. Current Topics in Med Chem. 2005 5 : 1005 16.
13. Zarubin T, Han J. Activation and signaling of the p38 MAP kinase pathway. Cell Res. 2005 15 : 11 8.
14. Sumbayev VV, Yasinska IM. Regulation of MAP kinase-dependent apoptotic pathway: implication of reactive oxygen and nitrogen species. Arch Biochem Biophys. 2005 436 : 406 12.
15. Das M, Cui J, Das DK. Generation of survival signal by differential interaction of p38MAPKα and p38MAPKβ with caveolin-1 and caveolin-3 in adapted heart. J Mol Cell Cardiol. 2007 42 : 206 13.
16. Maulik N, Engleman RM, Rouson JA, Flack JE, Deaton D, Das DK. Ischemia preconditioning reduces apoptosis by regulating anti-death gene Bcl-2. Circulation. 1999 100 : II369 75.
17. Beresewicz A, Maczewski M, Duda M. Effect of classic preconditioning and diazoxide on endothelial function and O2 and NO generation in the post-ischemic guineapig heart. Cardiovasc Res. 2004 172 : 201 10.
18. Ray PS, Martin JL, Swanson EA, Otani H, Dillmann WH, Das DK. Transgenic overexpression of B-crystallin confers simultaneous protection against cardiac myocyte apoptosis and necrosis during myocardial ischemia reperfusion. FASEB J. 2001 15 : 393 402.
19. Maulik N, Sasakli H, Addya S, Das DK. Regulation of cardiomyocyte apoptosis by redox sensitive transcription factor. FEBS lett. 2001 485 : 7 12.
20. Song KS, Li S, Okamoto T, Qutrilliam LA, Sargiacomo M, Lisanti MP. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae micro domain. J Biol Chem. 1996 271 : 9690 7.
21. Suzuki YJ, Nagase H, Day RM, Das DK. GATA-4 regulation of myocardial survival in preconditioned heart. J Mol Cell Cardiol. 2004 37 : 1195 203.
22. Vinten-Johansen J, Zhao ZQ, Nakamura M, Jordan JE, Ronson RS, Thourani VH, Guyton RA. Nitric oxide and the Vascular Endothelium in Myocardial Ischemia-Reperfusion Injury. In : DAS DK editor. Heart in Stress. Annals of The New York Academy of Sciences 1999, 412 26.
23. Das S, Otani H, Maulik N, Das DK. Redox regulation of angiotensin II preconditioning of the myocardium requires MAP kinase signaling. J Mol Cell Cardiol. 2006 41 : 248 55.
24. Murry CE, Richard VJ, Jennings RB and Reimer KA. Preconditionin? with ischemia: is the protective effect mediated by free radical induced myocardial stunning? Circulation. 1998 78 : 77 8.
25. Chen W, Gabel S, Steenbergen C, and Murphy E. A redox-based mechanism for cardio protection induced by ischemic preconditioning in perfused rat heart. Circ Res. 1995 77 : 424 429.
26. Osaka M, Takeda S, Sato T, Komori S, and Tamura K. The protective effect of preconditioning on reperfusion induced arrhythmias is lost by treatment with superoxide dismutase. Jpn Circ J. 1994 58 : 259 263.
27. Burke TM and Wolin MS. Hydrogen peroxide elicits pulmonary arterial relaxation and guanylate cyclase activation. Am J Physio. 1987 252 : H721 32.
28. Golino P, Ragni M, Cirillo P, Avvedimento VE, Feliciello A, Esposito N, Scognamiglio A, Trimarco B, Iaccarino B, Condorelli M, Chiariello M, and Ambrosio G. Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. Nat Med. 1996 2 : 35 40.
29. Reeves JP, Bailey CA, and Hale CC. Redox modification of sodium-calcium exchange activity in cardiac sarcolemmal vesicles. J Biol Chem. 1986 561 : 4948 55.
30. Das DK, Maulik N, Engleman RM. Redox regulation of Angiotensin II signaling in the heart. J Cell Mol Med. 2004 8 : 144 52.
31. Gorin Y, Ricono JM, Wagner B, Kim NH, Bhandari B, Choudhury GG. Angiotensin II-induced ERK1/ERK2 activation and protein synthesis are redox-dependent in glomerular mesangial cells. Biochem J. 2004 381 : 231 39.
32. Izawa Y, Yoshizumi M, Fujita Y, Ali N, Kanematsu Y, Ishizawa K. ERK1/2 activation by angiotensin II inhibits insulin-induced glucose uptake in vascular smooth muscle cells. Exp Cell Res. 2005 308 : 291 99.
33. Li JM, Wheatcroft S, Fan LM, Kearney MT, Shah AM. Opposing roles of p47phox in basal versus angiotensin II-stimulated alterations in vascular O2-production, vascular tone, and mitogen-activated protein kinase activation. Circulation. 2004 109 : 1307 1313.
34. Pinzar E, Wang T, Garrido MR, Xu W, Levy P, Bottari SP. Angiotensin II induces tyrosine nitration and activation of ERK1/2 in vascular smooth muscle cells. FEBS Lett. 2005 579 : 5100 4.
35. Booz GW, Day JN, Baker KM. Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure. J Mol Cell Cardiol. 2002 34 : 1443 53.
36. Xie Z, Pimental DR, Lohan S, Vasertriger A, Pligavko C, Colucci WS. Regulatio? of angiotensin II-stimulated osteopontin expression in cardiac microvascular endothelial cells: role of p42/44 mitogenactivated protein kinase and reactive oxygen species. J Cell Physiol. 2001 188 : 132 8.
37. Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, Griendling KK. p22 phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem. 1996 271 : 23317 21.
38. Kyaw M, Yoshizumi M, Tsuchiya K, Kirima K, Tamaki T. Antioxidants inhibit JNK and p38 MAPK activation but not ERK 1/2 activation by angiotensin II in rat aortic smooth muscle cells. Hypertens Res. 2001 24 : 251 61.